|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008976,
umls-concept:C0018801,
umls-concept:C0018802,
umls-concept:C0026538,
umls-concept:C0026565,
umls-concept:C0205191,
umls-concept:C0216784,
umls-concept:C1280500,
umls-concept:C1516048,
umls-concept:C1707689,
umls-concept:C2699007
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-9-14
|
|
pubmed:abstractText |
To investigate the role of persistent angiotensin activity despite angiotensin-converting enzyme inhibitor therapy in the progression of heart failure, the Valsartan Heart Failure Trial has been designed to investigate the effect of the angiotensin-receptor blocker, valsartan, on morbidity and mortality.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1071-9164
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
5
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
155-60
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10404355-Adolescent,
pubmed-meshheading:10404355-Adult,
pubmed-meshheading:10404355-Aged,
pubmed-meshheading:10404355-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:10404355-Chronic Disease,
pubmed-meshheading:10404355-Echocardiography, Doppler,
pubmed-meshheading:10404355-Female,
pubmed-meshheading:10404355-Follow-Up Studies,
pubmed-meshheading:10404355-Heart Failure,
pubmed-meshheading:10404355-Humans,
pubmed-meshheading:10404355-Male,
pubmed-meshheading:10404355-Middle Aged,
pubmed-meshheading:10404355-Multicenter Studies as Topic,
pubmed-meshheading:10404355-Quality of Life,
pubmed-meshheading:10404355-Randomized Controlled Trials as Topic,
pubmed-meshheading:10404355-Reference Values,
pubmed-meshheading:10404355-Research Design,
pubmed-meshheading:10404355-Severity of Illness Index,
pubmed-meshheading:10404355-Survival Rate,
pubmed-meshheading:10404355-Tetrazoles,
pubmed-meshheading:10404355-Treatment Outcome,
pubmed-meshheading:10404355-Valine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Rationale and design of the Valsartan Heart Failure Trial: a large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure.
|
|
pubmed:affiliation |
Department of Medicine, University of Minnesota Medical School, Minneapolis 55455, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
